Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

A.J.M. van den Eertwegh, J.P. Versluis, H.P. van den Berg, S.J.A.M. Santegoets, R.J.A. van Moorselaar, T.M. van der Sluis, H.E. Gall, T.C. Harding, K. Jooss, I. Lowy, H.M. Pinedo, R.J. Scheper, A.G.M. Stam, B.M.E. von Blomberg, T.D. de Gruijl, K. Hege, N. Sacks, W.R. Gerritsen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)509-517
JournalLancet Oncology
Volume13
Issue number5
DOIs
Publication statusPublished - 2012

Cite this